PANews August 12 news, according to PR Newswire, 180 Life Sciences (ETHZilla) announced that it currently holds a total of 82,186 Ethereum (ETH), with an average purchase price of $3,806.71, and a total market value of approximately $349 million. In addition, the company also holds about $238 million in cash equivalents. ETHZilla plans to hold the recently purchased ETH for the long term and intends to stake it using a proprietary Ethereum network strategy in collaboration with Electric Capital to generate returns. The company is accelerating its transformation into an Ethereum institutional-grade reserve management platform and continues to advance its gaming and biotechnology-related businesses.
